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Abstract Insulin is converted from the higher molecular weight proprotein, proinsulin by highly specific proteolytic cleavage at two dibasic amino 
acid sites. SPC3 and SPC2, two recently identified prohormone convertase that are specifically expressed in j9 cells and other neuroendocrine cells, 
appear to be responsible for those cleavages. We have sequenced the 5’-upstream region of the SPC3 gene and examined its promoter/enhancer activity 
and most of several deletion mutants in several cell lines. This region contains no CAAT box but has several non-functional TATA-like sequences 
and several putative transcriptional regulatory elements, including AP-I, Spl and CAMP response lements. These features are not unlike those of 
the human SPC2 upstream region. In /?TC3 insulinoma cells, the sequence between the EcoRI (620 bp) and NsiI (702 bp) sites seems to be important 
for gene expression, while the sequence between the NsiI and DraI (775 bp) sites may contain strong enhancer element(s). 
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1. Introduction 
Many peptide hormones and neuropeptides are synthesized 
as precursors that require highly specific proteolysis at exposed 
dibasic sites to release their secreted active forms. Proinsulin 
and POMC are examples of such precursors. Recently, two 
important members of a novel family of subtilisin-like endopep- 
tidases, SPC2 and SPC3, have been identified [1,2]. These two 
proteases appear to be responsible for the cleavage of various 
prohormones, including proinsulin and POMC [3,4], at dibasic 
sites in neuroendocrine (NE) tissues, especially brain, pancreas 
and pituitary [2]. Both SPC2 and SPC3 are expressed only in 
NE tissues but SPC2 is expressed at a high level in pancreatic 
p-cells [5] and the intermediate pituitary lobe [3,4], while SPC3 
is expressed at relatively high levels in the anterior pituitary 
corticotrophs and at lower levels in the pancreatic ~-cells [3,4]. 
The mechanisms by which differential expression of these en- 
zymes is controlled are not yet known. The nucleotide sequence 
of the human SPC2 promoter has no TATA or CAAT box, but 
has an extremely GC-rich region. Analysis of CAT activity of 
several deletion mutants shows that the region from - 1100 to 
-539 bp from the translation start site is essential for its pro- 
moter activity [6]. But there are no data on SPC3 promoter 
activity. Herein we investigate the regulation of the SPC3 gene. 
We report the nucleotide sequence of 2000 bp of S-flanking 
region proximal to the translation start site in the mouse SPC3 
gene and the results of expression studies. Using several dele- 
tion mutants linked to a luciferase cDNA, we have measured 
this reporter activity in pancreatic B-cell or pituitary cell lines, 
in comparison with a non-endocrine kidney cell line, and have 
defined regions within the SPC3 promoter that are probably 
responsible for its neuroendocrine cell-specific expression. 
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2. Materials and methods 
2.1. Isolation of genomic clones 
A mouse leukocyte genomic library constructed in lambda EMBL3 
(Cat# MLlO40j, Clonetech) was screened by the mouse SPC3 cDNA 
labeled by nick translation (Amersham). Fifteen positive plaques were 
found and screened by PCR using primers which are inside of exon 1 
and the positive clones were used for further analysis. 
2.2. Mapping, subcloning and sequencing 
The 6 kb insert of lambda clone was analyzed by restriction mapping 
and Southern blotting hybridization using a ‘*P end-labeled 20-base 
oligonucleotide 5’-AGTGAGTCCTCTAGCTCTAG-3’, correspond- 
ing to the immediately upstream region of exon 1 of the mouse SPC3 
gene. The appropriate restriction fragment was subcloned into pGEM 
32 (Promega) or pBluescript II KS (Stratagene) and sequenced by the 
dideoxynucleotide method, using either universal or specific primers. 
2.3. Construction of luczferase expression plasmids 
The luciferase expression plasmid @GLZ-basic) was obtained from 
Promega. To analyze the promoter activity, various constructs derived 
from a 6-kb genomic DNA fragment containing the putative promoter 
sequences immediately upstream from coding region were separated. 
We prepared constructs using natural sites in the 5’-flanking region of 
the SPC3 gene as follows: Sac1 -3.7 kb, SpeI -1.8 kb, SspI -1.2 kb, 
DraI -775 bp, NsiI -702 bp, EcoRI -620 bp, BgnI -284 bp relative 
to the ATG codon. These fragments were ligated to the luciferase 
expression plasmid and used in the expression experiments. 
2.4. Transfection experiments 
PC-3 mouse insulinoma cells, AtT-20 mouse anterior pituitary cells 
or COS7 monkey kidney cells were transiently transfected via electro- 
poration. Forty-eight hours before transfection, the cells were replated 
and grown to 70-808 confluency in 10 cm diameter tissue culture 
dishes. The cells were harvested and resuspended with 10 pg of a 
luciferase plasmid and 5 pg of pSV2-p-gal (containing /I-galactosidase 
cDNA and SV40 promoter) in 0.05 ml of DMEM medium without 
serum and electroporated at 250 V/800 PF (/?TC3 cells) or 350 V/800 
pF (AtT-20 cells) or 300 V/800 PF (COS7 cells) using a Cell-Porator 
(Gibco-BRL) and replated in 10 cm diameter cell culture dishes. 
2.5. Luciferase and P-galactosidase assay 
At 48 h after transfection, the cells were washed twice with PBS and 
incubated in 300~1 of Reporter Lysis buffer (Promega). The cell lysates 
were collected in 1.5 ml microcentrifuge tubes and debris was removed 
by centrifugation at 15,000 x g for 2 min at 4°C. The cell lysates were 
stored at -80°C until assay. /I-Galactosidase assays and luciferase 
assays were performed by kit (Promega) according to manufacturer’s 
protocol. The luciferase reaction mixture was placed in a Monolight 
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ACTGAACCCT TCATCAAGTC TTGCCTCGTT TTCATATAGT GGAGACCATC TCTTGCTTCT TT CTCTGTT TGTTGTAGTC CCCTTTCCCT GTAGTCTTCC 
TATGCCATGC ACCCTCCCCC ATCCTCCACT CCCACTCCCT TTAGGRGGTT RAATAATCTT TT CAGAAA?, ARAAAATACA CCTCTCAATT TCTTTTCCTT 
AAAGGTGAAC AAGATGCACA TAGTAACCAT CATGACCCTC ATCAGACTTC CACTAAGGCT CCTAGTTTGC TGTTCAAAGG AGGGAAAGAC CCAGGTCAAA 
CTGCTGAGAG CTGGCCAGGC AGCAGCGCCC TTTCKCTCA GARGGCTTTC ATAGAGGCAC TGAGATTATC GCTGTCCACA CATCGGTGCT GAATATTAAA 
ssp1 
TGCTCTCCTC TGTTCAATCC CTCCAGTTAG AGTCCATCAP. GGCAGTATGA TTGCTGTTTC GAAGGTGGGC ATAGGGACGT TCTCTTATCT CCCTCTRAGG 
TCCTCTTTGT TTCTTACTGT ATTTTATGTG AAAGTACCAG CACAGCTTCA AGTCAGTGCC AAAGTTAAAA TCTCCAGTGR GGGAAAAATA GRAAGTTCTG 
ACTTGCCACC TCCCTCACTG AGTCGATATG AAAGTCTTTG GGGCTCTGAA CCTCCTCGTT GAAAATTTAA AACATGTTTC TATGTTAAAA ACTCATGTTG 
G 
AGTCTTCCTT TTCTCCTTTT TAATGTAAAC ACTG?AATGA TGGTJGCCCTG GGCTCCAAAT GATCTCGGGT CGAATT:TAG AAACTGCTTT PGTAGGGGTC 
AGAAGCAAGA GAGGAGGART TACGAGTCAT TTAAARCGCA CTATAAAART GTTGTTTCAU CACTGTGTAG RGGAAGTGCT TATTTCCTTR CAGGATTTGA 
lJra1 
CAGGTAGCTT CGCTCCTCTG CTCCCRGCCT CTGAAAGATC ARAACACGAG TCCTRGATTG TGTCXTTTT RTRACAAP.TG CTGATACTCA AGAACCATTR 
RTCATCACCA GGCACATTCA TAGGAGATAT AAGGTAAGAT AGAGAAHRTA GATGGAAGGC GGQXTGGGA GGTAGGGAGT GAGGGGTAA? TGTTCTGCPT 
SPl 
GATCTTGGTA GTTATATTCA AATGAGGCGG TTCTCTTTGA AGAATGGAGA TGTTTCTCAC AGCTACAGTA TTTATGAACA GGCAGCAGAA CTGACCGATC 
CTTTTCCTTT TCTTAATCCT TCCCTGCCTA TTTTAGTCAC TTCTCCACL%Y&!XGGGAA TACCATCCAG TTCTCAGTCC AGGTACATCT F4CGmSBAGA 
AP-I SPl Bgl II CRE 
G 
GTCGATTTGA CGTGTAAACA CTCATTTCTA TTCTGGTTGG TAAGGCTGGG GCTCCACTCA GTCGGGAGAC TGAAGCACTT TAGTGAGCGC TCGJTCTCGCC 
TCCCAGTGAG CCTCTAGCTC TAGTAGAGCA ACCCAGAGCC AGGAGAGGTT TTAAGCTGCT GGGTGGAAAG GTCGAGTCTA GCTGGTGTGT CTCTGATCTT 
TCCCACCCCT TCCTACTTGT GTGAGAACAA GGTTTTGAGC C ATG GAG CAA AGA GGT 
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Fig. 1. Nucleotide sequence ofthe mouse SPC3 gene and 5’-flanking region. The putative regulatory elements are underlined and the restriction enzyme 
sites used for making the expression constructs are printed in bold. The nucleotides in italics at -868 and -168 are nucleotide insertions reported 
in the sequence of Ftouhi et al. [lo]. 
2010 luminometer (Analytical Luminescence Laboratories, San Diego, 
CA), and the light reaction was initiated by injection of lOO@ of 1 mM 
o-luciferin. Light emission was measured by integration over the initial 
10 s of the reaction. Each sample was measured three times and normal- 
ized to the B-galactosidase activity. 
3. Results and discussion 
Proinsulin is converted to insulin by cleavage at the B chain- 
C peptide junction (R-R&E) and the C-peptide-A-chain junc- 
tion (K-R&G) by SPC3 and SPC2, respectively, members of 
a recently discovered family of subtilisin and kex-related pro- 
teases that includes SPCl (furin), SPC2, SPC3 and several ad- 
ditional related enzymes [6]. Both SPC3 and SPC2 are specifi- 
cally expressed in brain and NE cells, but their relative abun- 
dance in various NE tissues differs. SPC2 is expressed at high 
levels in pancreatic a- and p-cells and the intermediate lobe of 
the pituitary, while SPC3 is expressed at relatively high levels 
in the anterior pituitary lobe and at somewhat lower levels in 
pancreatic B-cells. To investigate the regulation of the SPC3 
gene, we have sequenced the 5’-upstream region of SPC3 gene 
and compared it with the corresponding region of SPC2. The 
5’ region of the human SPC2 gene lacks TATA or CAAT boxes 
upstream of the transcription start sites but has a GC rich 
region [7]. We sequenced 2 kb of the lambda EMBL3 clone 
which contains 6 kb of 5’ upstream region of mouse SPC3. The 
nucleotide sequence of mouse SPC3 also contains no CAAT 
box but has several TATA-like and one GC-box like sequence. 
However, these TATA-like sequences eem to be non-func- 
tional, because they are relatively far from the transcription 
start sites. We also have noted several putative transcriptional 
regulatory sequences, including AP- 1, Sp 1 and CAMP-response 
elements. These features are not unlike those of the human 
SPC2 promoter and are consistent with other similarities be- 
tween these two genes and their presumed origin from a com- 
mon ancestral processing enzyme. On the other hand, another 
subtilisin like enzyme, furin (SPCl), is expressed in many tis- 
sues throughout the body and has three distinct promoters, 
only one of which has a TATA box [8]. 
We performed transient expression experiments using several 
SPC3 promoter fragments attached to a luciferase reporter 
gene. The PC3 cell line is a non clonal tumor cell line derived 
from insulinomas that developed in transgenic mice expressing 
the SV40 large T-antigen in the pancreatic islet B-cells [9]. These 
cells synthesize and secret processed insulin and express SPC2 
and SPC3 at medium to high levels. The AtT-20 cell line is also 
a tumor-derived cell line related to the anterior pituitary corti- 
cotrophs. It expresses a high level of SPC3, and very little SPC2. 
We used the COS7 cell line as a representative non endocrine 
cell line which does not have neuroendocrine characteristics 
and expresses neither SPC2 nor SPC3. In BTC3 cells, as shown 
in Fig. 2, the NsiI construct produced a 16-fold stimulation of 
luciferase activity and the DraI construct showed the greatest 
stimulation (over lOO-fold); the longer constructs exhibited 21- 
to 24-fold stimulation above the plasmid without promoter. 
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Fig. 2. Schematic onstructs containing fragments of S-flanking region of SPC3 and luciferase reporter gene, and their luciferase activities in /JTC3 
insulinoma cells. 
Thus, the sequence between the EcoRI (620 bp) and NsiI (702 
bp) sites (Fig. 1) seems to be important for SPC3 gene expres- 
sion while the sequence between the NsiI and DraI (775 bp) 
sites may contain strong enhancer element(s). The transfection 
results using the AtT20 cell line were similar, while the COS7 
cells exhibited no luciferase activity with any of these vectors. 
We conclude that the S-flanking region of the SPC3 gene re- 
sembles that of the human SPC2 gene; in the NE cells studied, 
702 bp immediately upstream of the initiator ATG of the mouse 
SPC3 gene is required for tissue-specific gene expression and 
a strong enhancer element(s) probably exists between 702 to 
775 bp from initiator ATG. 
Further studies will be necessary to determine the nature of the 
trans-acting factors responsible for the differential regulation 
of the SPC2 and SPC3 gene in various neuroendocrine cells. 
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